Daniel Parras

652 total citations
15 papers, 171 citations indexed

About

Daniel Parras is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Daniel Parras has authored 15 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Daniel Parras's work include Immune Cell Function and Interaction (3 papers), Diabetes and associated disorders (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Daniel Parras is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Diabetes and associated disorders (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Daniel Parras collaborates with scholars based in Spain, United States and Canada. Daniel Parras's co-authors include Pau Serra, Pere Santamaría, Carlota Dobaño, Natalia Rodrigo Melero, Ruth Aguilar, Gemma Moncunill, Carlo Carolis, Marta Vidal, Luís Izquierdo and Rebeca Santano and has published in prestigious journals such as Nature Communications, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

Daniel Parras

12 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Parras Spain 7 73 45 28 26 25 15 171
Martina Helbig Germany 7 40 0.5× 35 0.8× 34 1.2× 9 0.3× 25 1.0× 11 437
Jim Yee United States 8 194 2.7× 32 0.7× 49 1.8× 10 0.4× 13 0.5× 8 236
Natalia G. Herrera United States 4 175 2.4× 33 0.7× 36 1.3× 21 0.8× 32 1.3× 6 249
Camila Pereira Soares Brazil 8 148 2.0× 12 0.3× 9 0.3× 9 0.3× 19 0.8× 16 207
Patricia Almendro-Vázquez Spain 8 130 1.8× 70 1.6× 14 0.5× 14 0.5× 19 0.8× 12 191
Evangelia Petrisli Italy 8 102 1.4× 32 0.7× 19 0.7× 4 0.2× 20 0.8× 15 275
Alisha Kang Canada 7 110 1.5× 117 2.6× 33 1.2× 19 0.7× 43 1.7× 8 218
Collin C. McCourt United States 7 29 0.4× 116 2.6× 24 0.9× 18 0.7× 68 2.7× 11 243
Kevin Reyes United States 7 115 1.6× 34 0.8× 32 1.1× 6 0.2× 58 2.3× 22 234
Ane Fernandez Salinas Italy 7 139 1.9× 131 2.9× 14 0.5× 18 0.7× 22 0.9× 8 238

Countries citing papers authored by Daniel Parras

Since Specialization
Citations

This map shows the geographic impact of Daniel Parras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Parras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Parras more than expected).

Fields of papers citing papers by Daniel Parras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Parras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Parras. The network helps show where Daniel Parras may publish in the future.

Co-authorship network of co-authors of Daniel Parras

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Parras. A scholar is included among the top collaborators of Daniel Parras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Parras. Daniel Parras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Friedman, Eleanor E., Samantha A. Devlin, Geoffroy Liégeon, et al.. (2025). PrEP Prescriptions at 2 Federally Qualified Health Centers. Sexually Transmitted Diseases. 53(3). e26–e28.
2.
Parras, Daniel, et al.. (2025). Chronic Viral Hepatitis Screening Inequities Across Florida Federally Qualified Health Centers. Journal of Racial and Ethnic Health Disparities.
3.
Christy, Shannon M., Mariana Arévalo, Lindsay Fuzzell, et al.. (2024). HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS): Study protocol for a hybrid 1 stepped-wedge cluster randomized trial. Contemporary Clinical Trials. 142. 107576–107576.
4.
Nicolini, Fabio, Roberta Maltoni, Matteo Marchesini, et al.. (2024). Significant Advancements and Evolutions in Chimeric Antigen Receptor Design. International Journal of Molecular Sciences. 25(22). 12201–12201. 4 indexed citations
5.
Parras, Daniel, Jun Yamanouchi, Nahir Garabatos, et al.. (2023). Transcriptional re-programming of insulin B-chain epitope-specific T-follicular helper cells into anti-diabetogenic T-regulatory type-1 cells. Frontiers in Immunology. 14. 1177722–1177722. 10 indexed citations
6.
Heintzman, John, Daniel Parras, Jennifer Lucas, et al.. (2023). The role of language in mammography orders among low-income Latinas over a 10-year period. Preventive Medicine. 175. 107657–107657. 4 indexed citations
7.
Horigian, Viviana E., Renae D. Schmidt, Rui Duan, et al.. (2023). Untreated substance use disorder affects glycemic control: Results in patients with type 2 diabetes served within a network of community-based healthcare centers in Florida. Frontiers in Public Health. 11. 1122455–1122455. 2 indexed citations
8.
Nasir, Md, et al.. (2023). Using Data Science and a Health Equity Lens to Identify Long-COVID Sequelae Among Medically Underserved Populations. Journal of Health Care for the Poor and Underserved. 34(2). 521–534. 2 indexed citations
9.
Rubio, Rocío, Ruth Aguilar, Mariona Bustamante, et al.. (2022). Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile. Frontiers in Immunology. 13. 999136–999136. 26 indexed citations
10.
Serra, Pau, et al.. (2022). Structural plasticity in I-Ag7 links autoreactivity to hybrid insulin peptides in type I diabetes. Frontiers in Immunology. 13. 924311–924311. 2 indexed citations
11.
Dobaño, Carlota, Anna Ramírez‐Morros, Selena Alonso, et al.. (2021). Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19. BMC Medicine. 19(1). 155–155. 24 indexed citations
12.
Parras, Daniel, et al.. (2021). Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor. Frontiers in Immunology. 12. 737428–737428. 12 indexed citations
13.
Dobaño, Carlota, Marta Vidal, Rebeca Santano, et al.. (2020). Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens. Journal of Clinical Microbiology. 59(2). 58 indexed citations
14.
Cano, Miguel Ángel, Flavio F. Marsiglia, Alan Meca, et al.. (2020). Psychosocial stress, bicultural identity integration, and bicultural self‐efficacy among Hispanic emerging adults. Stress and Health. 37(2). 392–398. 9 indexed citations
15.
Serra, Pau, Nahir Garabatos, Santiswarup Singha, et al.. (2019). Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules. Nature Communications. 10(1). 4917–4917. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026